Aimovig (Erenumab-aooe) for Migraine | MyMigraineTeam
Aimovig is also the first member of a new class of drugs called calcitonin gene-related peptide receptor (CGRP-R) antagonists. Aimovig is believed to work by interfering with CGRP, a substance that
Anti-CGRP Migraine Preventive Medication | Aimovig
Learn about Aimovig®, a prescription medicine for the preventive treatment of migraine in adults. See Full Prescribing & Safety Info.
Is Aimovig Migraine Medicine an Advance or a Breakthrough?
“Migraine sufferers should also know that a new drug (Aimovig) has been released that is probably the biggest improvement in migraine treatment in decades because of its limited side effects.”
FDA approves novel preventive treatment for migraine
Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide, a molecule that is involved in...
Aimovig: A Breakthrough Migraine Medication
A: Aimovig is a migraine treatment in a new class of medications called CGRP monoclonal antibodies. This medication has been FDA-approved for the preventive treatment of migraine, and
Migraine Prevention Treatment | Aimovig® (erenumab-aooe) HCP
Learn how Aimovig® helps healthcare professionals (HCPs) support patients through their migraine prevention treatment. See Full Prescribing & Safety Info.
What to Know About the New FDA-Approved Drug Aimovig
The FDA has approved a new drug for migraine prevention. Current studies on the new preventive treatment, Aimovig, have shown promising results to decrease the frequency of migraine attacks in
FDA Approves Aimovig™ (erenumab-aooe), A Novel Treatment
Aimovig is a novel therapeutic approach as the first and only FDA -approved treatment specifically developed to prevent migraine by blocking the calcitonin gene-related peptide receptor (CGRP-R) –
Aimovig for Migraine Prevention: Key Insights and
FDA Approves Novel Preventive Treatment for Migraine. Aimovig is available as a once-monthly injection in an auto-injector pen or a prefilled syringe. Aimovig is a monoclonal antibody
Aimovig: Uses, Dosage, and Side Effects
Aimovig works by blocking the effect of calcitonin gene-related peptide (CGRP), a small protein involved in migraines that increases during a migraine attack. By blocking CGRP, Aimovig
PDF version includes complete article with source references. Suitable for printing and offline reading.